Summary
PATHOLOGIE has been active since 1997 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €4,324. Equity remains stable across the filed fiscal years (±0% per year). Its solvency ranks better than 5% of 2386 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Checked score
No current score
Insufficient figures
A score requires measurable solvency, liquidity and profitability. Missing figures are not a judgement about the company.
Axes · tick = 2024
Profitability-
Solvency25▼-2
Growth35▼-20
Track record100
Bankruptcy probability, 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Six signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Human health activities (NACE 86)
about 87% fewer bankruptcies
← fewer bankruptcies
more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
0.4%
Age of the figures
9 mo
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 5% of 2386 sector peers (2025).
NBB · sector comparisonPosition among 2386 sector peers
Solvency
better than 5%
← weakest
strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 09-07-2026, 22 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
22 d early
2024
21 d early
2023
15 d early
2022
38 d early
2021
33 d early
2020
26 d early
2019
29 d early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 7 accounts on average 26 days before the deadline; the sector median for financial year 2024 is 7 days before the deadline, and 36% of the sector filed late.
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 9 July (5 of the last 5 filed years within 30 days of that day).
Companies Code · seven monthsPosition in the running window
30-09-2026 today31-12-2026 close31-07-2027 deadline
History
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed
Is this your company? See how customers and banks see it.
Investigating this company? Keep it with today's facts in a case file.
Financials · fiscal year 2025, abbreviated schema
In the rankings
#4 oldest company in Ingelmunster, Health and social work sector#9 company by total assets in Ingelmunster, Health and social work sector
Equity
€4,324▼ 82.2%
2024 · €24,233
Total assets
€988,601▼ 15.6%
2024 · €1.2m
Net result
€0
Working capital
€4,324▼ 82.2%
2024 · €24,233
Trend over the years
Click a name to add, emphasise or remove a line.Band: the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings. Dashed line: the median.
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20212022202320242025
Operating result€145▲ 2.1%€580▲ 299%€1,039▲ 79.0%€632▼ 39.2%-€489
Net result
Equity€24,233below the sector's middle half=€24,233below the sector's middle half=€24,233below the sector's middle half=€24,233below the sector's middle half=€4,324below the sector's middle half▼ 82.2%
Total assets€1.0mwithin the sector's middle half▲ 43.2%€874,094within the sector's middle half▼ 13.4%€1.0mwithin the sector's middle half▲ 15.7%€1.2mwithin the sector's middle half▲ 15.7%€988,601within the sector's middle half▼ 15.6%
Debt€985,568▲ 44.7%€849,861▼ 13.8%€987,525▲ 16.2%€1.1m▲ 16.1%€984,276▼ 14.2%
Working capital€1.0mabove the sector's middle half▲ 43.2%€872,340above the sector's middle half▼ 13.6%€24,233below the sector's middle half▼ 97.2%€24,233below the sector's middle half=€4,324below the sector's middle half▼ 82.2%
Solvency2.4%below the sector's middle half▼ 1.0pp2.8%below the sector's middle half▲ 0.4pp2.4%below the sector's middle half▼ 0.4pp2.1%below the sector's middle half▼ 0.3pp0.4%below the sector's middle half▼ 1.6pp
Current ratio1.02below the sector's middle half1.02below the sector's middle half=1.00below the sector's middle half▼ 0.02
Return on assets (ROA)
above
within
below
the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings.
Turnover and EBIT margin not published: the abbreviated schema does not require them.
Result per fiscal year
Operating result
The operating result turns negative in 2025: a loss of €489 after €632 in 2024, the lowest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Equity and liabilities €988,601
Equity
€4,324 ▼ 82.2%
Debt
€984,276 ▼ 14.2%
Debt's share of the balance-sheet total rises from 97.9% to 99.6%. Equity and debt are lower.
Key figures and ratios
Debt ≤ 1 year
€984,276▼
2024 · €1.1m
Income taxes
-€534▼
2024 · €588
A ratio outside any meaningful range has been withheld (balance sheet total €988,601, equity €4,324).
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Annual accounts
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Other operating charges640/8 | €1,099 | €580 | €1,195 | €1,214 | €1,246 | ▲ 2.7% |
| Gross operating margin9900 | €1,244 | €1,160 | €2,234 | €1,845 | €757 | ▼ 59.0% |
| Operating profit (loss)9901 | €145 | €580 | €1,039 | €632 | -€489 | ▼ 177% |
| Financial income75/76B | - | - | - | - | €0 | - |
| Recurring financial income75 | - | - | - | - | €0 | - |
| Financial charges65/66B | €37 | €60 | €39 | €43 | €45 | ▲ 3.5% |
| Recurring financial charges65 | €37 | €60 | €39 | €43 | €45 | ▲ 3.5% |
| Profit (loss) for the period before taxes9903 | €109 | €520 | €1,000 | €588 | -€534 | ▼ 191% |
| Income taxes67/77 | €109 | €520 | €1,000 | €588 | -€534 | ▼ 191% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €1.0m | €874,094 | €1.0m | €1.2m | €988,601 | ▼ 15.6% |
| Current assets29/58 | €1.0m | €874,094 | €1.0m | €1.2m | €988,601 | ▼ 15.6% |
| Amounts receivable within one year40/41 | €905,538 | €766,259 | €902,019 | €1.1m | €846,293 | ▼ 19.6% |
| Trade receivables40 | - | - | - | €2,628 | €0 | ▼ 100% |
| Other amounts receivable41 | €905,538 | €766,259 | €902,019 | €1.0m | €846,293 | ▼ 19.4% |
| Cash at bank and in hand54/58 | €104,263 | €107,615 | €108,739 | €118,828 | €142,307 | ▲ 19.8% |
| Deferred charges and accrued income490/1 | - | €220 | €1,000 | €0 | - | - |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €1.0m | €874,094 | €1.0m | €1.2m | €988,601 | ▼ 15.6% |
| Equity10/15 | €24,233 | €24,233 | €24,233 | €24,233 | €4,324 | ▼ 82.2% |
| Contributions10/11 | €22,415 | €22,415 | €22,415 | €22,415 | €4,324 | ▼ 80.7% |
| Capital10 | €18,600 | €18,600 | €18,600 | - | - | - |
| Issued capital100 | €18,600 | €18,600 | €18,600 | - | - | - |
| Outside capital11 | €3,815 | €3,815 | €3,815 | - | - | - |
| Share premium1100/10 | €3,815 | €3,815 | €3,815 | - | - | - |
| Reserves13 | €1,819 | €1,819 | €1,819 | €1,819 | €0 | ▼ 100% |
| Non-distributable reserves130/1 | €1,416 | €1,416 | €1,416 | €1,416 | €0 | ▼ 100% |
| Legal reserve130 | €1,416 | €1,416 | €1,416 | - | - | - |
| Reserves not available under the articles1311 | - | - | - | €1,416 | €0 | ▼ 100% |
| Distributable reserves133 | €403 | €403 | €403 | €403 | €0 | ▼ 100% |
| Profit (loss) carried forward14 | - | - | - | - | €0 | - |
| Amounts payable17/49 | €985,568 | €849,861 | €987,525 | €1.1m | €984,276 | ▼ 14.2% |
| Amounts payable within one year42/48 | €79 | €1,754 | €987,525 | €1.1m | €984,276 | ▼ 14.2% |
| Trade debts44 | €79 | €1,754 | €13,091 | €8,326 | €18,439 | ▲ 121% |
| Suppliers440/4 | €79 | €1,754 | €13,091 | €8,326 | €18,439 | ▲ 121% |
| Other amounts payable47/48 | - | - | €974,434 | €1.1m | €965,837 | ▼ 15.2% |
| Accrued charges and deferred income492/3 | €985,489 | €848,107 | €0 | - | - | - |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Change in cash | - | €3,352 | €1,124 | €10,089 | €23,479 | ▲ 133% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
10-09
State Gazette act
Appointment: Dr. Marie Behaeghe - Pathologische Anatomie (non-statutory director)Permanent representatives: Marie BEHAEGHE, Veerle MERTENS and Franceska DEDEURWAERDERE5 facts ▸
State Gazette act
Appointment: Dr. Marie Behaeghe - Pathologische Anatomie (non-statutory director)
Permanent representatives: Marie BEHAEGHE, Veerle MERTENS and Franceska DEDEURWAERDERE5 facts ▸
- General meeting, 09-06-2026
- Director appointment, Dr. Marie Behaeghe - Pathologische Anatomie (non-statutory director)
- Permanent representative, Marie BEHAEGHE (permanent representative)
- Permanent representative, Veerle MERTENS (permanent representative)
- Permanent representative, Franceska DEDEURWAERDERE (permanent representative)
09-07
NBB filing
Annual accounts filed
fiscal year 2025 · abbreviated schema
2025
10-07
NBB filing
Annual accounts filed
fiscal year 2024 · abbreviated schema
2024
16-07
NBB filing
Annual accounts filed
fiscal year 2023 · abbreviated schema
2023
23-06
NBB filing
Annual accounts filed
fiscal year 2022 · abbreviated schema
2022
28-06
NBB filing
Annual accounts filed
fiscal year 2021 · abbreviated schema
2021
05-07
NBB filing
Annual accounts filed
fiscal year 2020 · abbreviated schema
2020
02-07
NBB filing
Annual accounts filed
fiscal year 2019 · abbreviated schema
2019
02-07
NBB filing
Annual accounts filed
fiscal year 2018 · abbreviated schema
2018
11-07
NBB filing
Annual accounts filed
fiscal year 2017 · abbreviated schema
2017
06-07
NBB filing
Annual accounts filed
fiscal year 2016 · abbreviated schema
State Gazette actNBB filing
1 of 11 acts read
About the unread acts
Of the 11 Belgian State Gazette acts we know for this company, 1 has been read. The other 10 have not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
1 director, last change in 2026
Board 1
Dr. Marie Behaeghe - Pathologische Anatomie
CurrentNon-statutory director · since 09-06-2026 · Private limited company · perm. rep.: Marie BEHAEGHE
Permanent representatives 1
Marie BEHAEGHE
CurrentPermanent representative · since 09-06-2026 · for Dr. Marie Behaeghe - Pathologische Anatomie
Derived from published Gazette acts. The CBE keeps the official list of function holders; we do not read it, so the two can differ.
See the function holders in the CBE →
Not every act has been read: a resignation may be missing here
10 of this company's 11 Belgian State Gazette acts have not been read yet. Appointments and resignations recorded in them are missing above: a director who resigned there may therefore still show here as sitting. The acts are in the Timeline.
Location & real-estate footprint
Registered office, Ingelmunster · 4 establishment units since 1997
Ground area
18.5 ha
Building footprint
4.6 ha
Volume, LiDAR
116,780 m³
5 parcels, Flanders · tallest building 23.6 m, ±4 floors. Linked by address, not a title deed.
2
companies at this address
See who is registered here
4 establishment units
O.L.V. van Lourdes Ziekenhuis Waregem
since 19972.212.929.195
Sint-Andriesziekenhuis
since 19972.212.929.492
H.- Hartziekehuis Roeselare-Menen
since 19972.212.929.591
AZ Groeninge
since 19972.212.930.284
5 parcels
Flanders
5
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 34026A0631/00H000 | Flanders | 13.7 ha | 1 · 3.4 ha | - |
| 34040C0214/00L000 | Flanders | 4.1 ha | 1 · 9,552 m² | 23.6 m · 4 fl. |
| 37015K0210/00B002 | Flanders | 5,500 m² | 1 · 2,024 m² | - |
| 36007B0508/00T000 | Flanders | 1,394 m² | 1 · 232 m² | 13.6 m · 3 fl. |
| 36503C0998/00Y009 | Flanders | 449 m² | 1 · 121 m² | 10.2 m · 1 fl. |
Linked by address, not proof of ownership
Good to know
5 of 5 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Mandate history
1 person since 2026, 1 in office
- Board
| Name | Functions and periods |
|---|---|
| Dr. Marie Behaeghe - Pathologische Anatomie |
|
Structure & network
Owners and holdings
5 ownersOwners 5
-
25%
-
20%
-
16.67%
-
16.67%
-
16.67%
Holdings 0
No holding stated in the accounts, acts or LEI register we read.
According to the annual accounts of the other companies, the acts in the Belgian Gazette and the LEI register. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not fill in these statements, or need not, is missing.
Connections & network
1 current directorThe network starts from this company’s directors. Other companies they run appear here as nodes.
This company
Company
Director
Shareholding
+N: links not shown yet
Click a node to look further, drag to arrange, scroll to zoom.
Similar companies · same sector, comparable size
Dr. Silke Van Genechten – Cardiothoracaal Chirurg
BE 0797.194.597
Genk · Eq €4,314
INSTITUT MEDICAL DE JURBISE
BE 0891.398.425
Jurbise · Eq €4,251
MDRD
BE 0753.523.318
Hasselt · Eq €4,240
Docteur Bastien DEVET
BE 1000.878.860
Liège · Eq €4,216
DR. KLARA WYFFELS
BE 0764.309.025
Brugge · Eq €4,462
Of 16,627 companies in sector 86220 we hold annual accounts for 7,988. 1,359 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPrivate limited company
Founded25-07-1997
Fiscal year end31-12
Abbreviation NL
PATH
Activities, NACEBEL 2025
86220Specialist medical practice
E-invoicing
Reachable via Peppol
Peppol ID
0208:0461220647
Also
9925:BE0461220647
Registered
16-07-2026
If you follow this company, Checked tells you the day it leaves the Peppol register.
Register as of 30 September 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.